Emerging treatment options for myelofibrosis: focus on pacritinib

Myelofibrosis (MF) is a myeloid malignancy associated with a heavy symptomatic burden that decreases quality of life and presents a risk for leukemic transformation. While there are limited curative treatments, the recent discovery of the Janus kinase/signal transducer and activator of transcription...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Onco Targets Ther
Main Authors: Chow, Vivian, Weissman, Ashley, O’Connell, Casey Lee, Mehrvar, Azim, Akhtari, Mojtaba
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2016
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4863690/
https://ncbi.nlm.nih.gov/pubmed/27226728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S93875
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki